Sabry, Waleed <br/><br/>
Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Aug 2009 
 - 919-29 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2009.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Chemoprevention--methods<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>HLA Antigens<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Histocompatibility<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--administration & dosage<br/>Outpatients<br/>Survival Analysis<br/>Tacrolimus--administration & dosage<br/>Transplantation Conditioning--methods<br/>Young Adult